Abstract

The potential benefit of off-pump coronary artery bypass graft (OPCAB) in patients with severe left ventricular (LV) dysfunction is unknown. We performed a multi-center longitudinal analysis of OPCAB versus on-pump coronary artery bypass graft (ONCAB) in patients with LV ejection fraction (LVEF)≤35%. Between 10/2008 03/2016, 50,115 cases of primary isolated coronary artery bypass grafting (CABG) were performed in Ontario, Canada. Of 6034 patients (12%) with LVEF≤35%, 1116/6034 (18.5%) underwent OPCAB and 4918/6034 (81.5%) underwent ONCAB. Propensity score matching resulted in 1055 identical pairs. Mean and maximum follow-up were 4.1 and 8.5 years, respectively. Primary outcome was major adverse cardiac and cerebrovascular events (MACCE), a composite endpoint of death, stroke, acute myocardial infarction (AMI), and repeat revascularization. OPCAB was associated with improved 30-day freedom from MACCE (HR 0.62[0.44- 0.87], p< 0.01), survival (HR 0.60[0.38-0.96], p=0.03) and AMI (HR 0.22[0.05-1.03], p=0.04). OPCAB was also associated with lower in-hospital stroke (<0.5% vs 1.8%, p 0.01), renal dysfunction requiring dialysis (0.9% vs 2.5%, p<0.01). At 8 years, there were no differences in freedom from MACCE (Figure 1) (HR 0.95[0.82-1.10], p=0.44), survival (HR 0.92[0.77-1.09], p=0.23), and re-hospitalization for heart failure (HR 1.08[0.90- 1.29], p=0.40). Total number bypass grafts for OPCAB vs ONCAB were similar (3.29±1.2 vs 3.31±1.0, p=0.61). OPCAB was associated with improved short-term MACCE in patients with LV dysfunction, but no difference in long term outcomes was observed. The total number of grafts were similar between groups.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call